Other disorders of glucose regulation and pancreatic internal secretion (E15-E16)

E15Nondiabetic hypoglycemic coma
Includes: drug-induced insulin coma in nondiabetic
› hyperinsulinism with hypoglycemic coma
› hypoglycemic coma NOS

E16Other disorders of pancreatic internal secretion

E16.0Drug-induced hypoglycemia without coma
Excludes 1: diabetes with hypoglycemia without coma (E09.649)
Use Additional Code: code for adverse effect, if applicable, to identify drug (T36-T50) with fifth or sixth character 5)

E16.1Other hypoglycemia
› Functional hyperinsulinism
› Functional nonhyperinsulinemic hypoglycemia
› Hyperinsulinism NOS
› Hyperplasia of pancreatic islet beta cells NOS
Excludes 1: diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649)
› hypoglycemia in infant of diabetic mother (P70.1)
› neonatal hypoglycemia (P70.4)

E16.2Hypoglycemia, unspecified
Excludes 1: diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649)

E16.3Increased secretion of glucagon
› Hyperplasia of pancreatic endocrine cells with glucagon excess

E16.4Increased secretion of gastrin
› Hypergastrinemia
› Hyperplasia of pancreatic endocrine cells with gastrin excess
› Zollinger-Ellison syndrome

E16.8Other specified disorders of pancreatic internal secretion
› Increased secretion from endocrine pancreas of growth hormone-releasing hormone
› Increased secretion from endocrine pancreas of pancreatic polypeptide
› Increased secretion from endocrine pancreas of somatostatin
› Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide

E16.9Disorder of pancreatic internal secretion, unspecified
› Islet-cell hyperplasia NOS
› Pancreatic endocrine cell hyperplasia NOS